Language Disorders
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
[Transudative bile peritonitis in the elderly].
|
516625 |
1979 |
Abnormal behavior
|
0.310 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
[Transudative bile peritonitis in the elderly].
|
516625 |
1979 |
Intellectual Disability
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
[Transudative bile peritonitis in the elderly].
|
516625 |
1979 |
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
[Transudative bile peritonitis in the elderly].
|
516625 |
1979 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Our findings thus suggest that heterozygous constitutive deletion of Nurr1 results in a restricted phenotype characteristic of schizophrenia symptomatology, which primarily relates to motor activity, sensorimotor gating and responsiveness to the psychomimetic drug MK-801.
|
21545404 |
2011 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Evidence by others support this hypothesis (1) mapping of the NR4A2 gene to chromosome 2q22-23, a region with suggestive linkage to schizophrenia and (2) identification of mutations in patients with schizophrenia (c.366-369delTAC, c.308A > G, c.-469delG), manic depression (c.289A > G), and familial Parkinson's disease (c.-291delT, c.-245T > G).
|
15211629 |
2004 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
PSYGENET |
These data show a deficient prefrontal NGFI-B and Nurr1 expression in schizophrenia and bipolar disorder.
|
16631355 |
2006 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
PSYGENET |
This suggests that the Nurr1 mutant mouse may be a potential animal model for studies on some of the behavioral and molecular mechanisms underlying schizophrenia.
|
17457314 |
2007 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
PSYGENET |
The nuclear receptor Nurr1 functions to regulate dopamine neurotransmission, as Nurr1-null heterozygous (+/-) mice have alterations in dopamine function and, when raised in isolation immediately after weaning, have disruptions in sensorimotor gaiting, a behavior altered in schizophrenia and modulated by dopamine neurotransmission.
|
18655117 |
2008 |
Bipolar Disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
These data show a deficient prefrontal NGFI-B and Nurr1 expression in schizophrenia and bipolar disorder.
|
16631355 |
2006 |
Alcoholic Intoxication, Chronic
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms in the regulatory region of Nurr1 are implicated in pathogenesis of alcohol dependence and the Nurr1/dopamine signaling pathway might be important for this dependence development in Mexican Americans.
|
23066323 |
2012 |
Cocaine Abuse
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In the present study, we show that each of these transcription factors is robustly expressed in adult dopamine neurons in human midbrain, and that cocaine abuse is associated with a significant decrease in the abundance of Nurr1 and Pitx3 in these cells.
|
15094491 |
2004 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Nurr1 protein in BA 9 was significantly lower in major depression (P<0.05) and lower at a trend level in schizophrenia (P=0.056) than in the controls.
|
16631355 |
2006 |
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Nurr1 protein in BA 9 was significantly lower in major depression (P<0.05) and lower at a trend level in schizophrenia (P=0.056) than in the controls.
|
16631355 |
2006 |
Parkinsonian Disorders
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Constipation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle Rigidity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sleep disturbances
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Urgency of micturition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bradykinesia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|